Pitavastatin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pitavastatin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pitavastatin Today - Breaking & Trending Today

A Closer Look at the New Statin Therapy Guidelines for Patients With HIV

Clinicians can use these recommendations to navigate primary CVD prevention efforts ....

United States , American College Of Cardiology , Medicine Association , American Heart Association , African American , People Living With , Endpoint Driven , Advancing Clinical Therapeutics Globally , New Recommendations , Statin Therapy , People With , American College , Primary Prevention , Cardiovascular Disease ,

#VisualAbstract: Pitavastatin reduces cardiovascular event risk among patients with HIV

1. In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, pitavastatin calcium was superior to placebo in reducing the risk of a major adverse cardiovascular event (MACE). 2. The trial was stopped early due to evidence of the efficacy and safety of pitavastatin. Evidence Rating ....

United States , American College Of Cardiology , American Heart Association , Minute Medicine Inc , Rating Level , American College , Confidence Interval , Anti Retroviral Therapy , Chronic Disease , Infectious Disease , Major Adverse Cardiovascular Events , Public Health ,

Pitavastatin reduces cardiovascular event risk among patients with HIV

1. In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, pitavastatin calcium was superior to placebo in reducing the risk of a major adverse cardiovascular event (MACE). 2. The trial was stopped early due to evidence of the efficacy and safety of pitavastatin. Evidence Rating ....

United States , Minute Medicine Inc , American College Of Cardiology , American Heart Association , Rating Level , American College , Confidence Interval , Anti Retroviral Therapy , Chronic Disease , Human Immunodeficiency Virus Hiv , Infectious Disease , Major Adverse Cardiovascular Events , Public Health ,

Daily Pitavastatin Reduces Cardiovascular Risk in People With HIV

Among people living with HIV receiving antiretroviral therapy, those taking 4-mg pitavastatin daily were 35% less likely than those taking placebo to experience a major cardiovascular event over 5 years of follow-up. ....

New England Journal , Prevent Vascular Events , Cholesterol Treatment Trialist Collaboration , Vldl Cholesterol ,

HIV patients face double the risk of heart disease. Taking a statin could help

Scientists have long known that people living with HIV face a higher risk of heart disease. The drug pitavastatin, however, might offer a solution. ....

United States , Patrice Desvigne Nickens , Steven Grinspoon , Harvard Medical School , American College Of Cardiology , Blood Institute Division Of Cardiovascular Sciences , National Heart , American Heart Association , New England Journal , Blood Institute , Cardiovascular Sciences , American College , Saharan Africa , South America , Heart Attacks , Heart Disease , Heart Complications , Ntiretroviral Medication , Hiv Infection , Living With Hiv , Statin Drug , Heart Failure , Esvigne Nickens ,